Cargando…
Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study()
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201310/ https://www.ncbi.nlm.nih.gov/pubmed/37308357 http://dx.doi.org/10.1016/j.medine.2023.05.009 |
| _version_ | 1785045239928455168 |
|---|---|
| author | Bermúdez-Ruiz, María del Carmen Vilar Sánchez, Irene Aparicio Pérez, Clara Carmona Flores, Rosario Rodríguez-Gómez, Jorge de la Fuente-Martos, Carmen |
| author_facet | Bermúdez-Ruiz, María del Carmen Vilar Sánchez, Irene Aparicio Pérez, Clara Carmona Flores, Rosario Rodríguez-Gómez, Jorge de la Fuente-Martos, Carmen |
| author_sort | Bermúdez-Ruiz, María del Carmen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10201310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102013102023-05-22 Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() Bermúdez-Ruiz, María del Carmen Vilar Sánchez, Irene Aparicio Pérez, Clara Carmona Flores, Rosario Rodríguez-Gómez, Jorge de la Fuente-Martos, Carmen Med Intensiva (Engl Ed) Scientific Letter Published by Elsevier España, S.L.U. 2023-05-22 /pmc/articles/PMC10201310/ /pubmed/37308357 http://dx.doi.org/10.1016/j.medine.2023.05.009 Text en © 2023 Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Bermúdez-Ruiz, María del Carmen Vilar Sánchez, Irene Aparicio Pérez, Clara Carmona Flores, Rosario Rodríguez-Gómez, Jorge de la Fuente-Martos, Carmen Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() |
| title | Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() |
| title_full | Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() |
| title_fullStr | Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() |
| title_full_unstemmed | Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() |
| title_short | Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study() |
| title_sort | clinical experience of prophylactic enoxaparin dosage adjustment guided by antixa factor levels in critical care patients with covid-19-induced pneumonia: observational study() |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201310/ https://www.ncbi.nlm.nih.gov/pubmed/37308357 http://dx.doi.org/10.1016/j.medine.2023.05.009 |
| work_keys_str_mv | AT bermudezruizmariadelcarmen clinicalexperienceofprophylacticenoxaparindosageadjustmentguidedbyantixafactorlevelsincriticalcarepatientswithcovid19inducedpneumoniaobservationalstudy AT vilarsanchezirene clinicalexperienceofprophylacticenoxaparindosageadjustmentguidedbyantixafactorlevelsincriticalcarepatientswithcovid19inducedpneumoniaobservationalstudy AT aparicioperezclara clinicalexperienceofprophylacticenoxaparindosageadjustmentguidedbyantixafactorlevelsincriticalcarepatientswithcovid19inducedpneumoniaobservationalstudy AT carmonafloresrosario clinicalexperienceofprophylacticenoxaparindosageadjustmentguidedbyantixafactorlevelsincriticalcarepatientswithcovid19inducedpneumoniaobservationalstudy AT rodriguezgomezjorge clinicalexperienceofprophylacticenoxaparindosageadjustmentguidedbyantixafactorlevelsincriticalcarepatientswithcovid19inducedpneumoniaobservationalstudy AT delafuentemartoscarmen clinicalexperienceofprophylacticenoxaparindosageadjustmentguidedbyantixafactorlevelsincriticalcarepatientswithcovid19inducedpneumoniaobservationalstudy |